Cordis Corporation Release: New Stent Delivery System Allows Physicians To Treat Life-Threatening Biliary Blockages

WARREN, N.J., June 8 /PRNewswire/ -- Cordis Endovascular, a division of Cordis Corporation, today launched the PALMAZĀ® BLUE(TM) .014 Transhepatic Biliary Stent, the latest advancement in balloon-expandable stent delivery technology, to treat biliary blockages. A biliary stent is often used to open blockages in the bile ducts to promote the flow of fluids from the liver, gallbladder and pancreas to the small intestines. Each year, more than 30,000 Americans are affected by life-threatening blockages in the bile ducts, leading to the need for treatment.

Back to news